Ann: Lyell McEwin Hospital approved to join PharmAust trial, page-115

First 115 Last

Share
Profile

Follow
elit

13,316 Posts.

168

09/04/15

19:54

Post #: 15060528
Share

Originally posted by Ace of Spades ↑

PAA is definitely the most exciting and novel Cancer drug company on the ASX.

Pitneys lead drug PPL1 has been able to show reductions in key Cancerous Tumor Markers in its ongoing Phase I human trials.
Excitingly, the drug, Monepantel, is a new class of anti-cancer and it's the first time it's ever been used in humans.
The amazing part about the great news was the fact that PAA were doing a preliminary safety study on PPL1 (Phase 1) and yet the drug at its lowest dose was able to show a marked reduction of between 8% and 65% in 4 out of 4 patients taking part in the trial.

Of further great importance is the fact that all participants in the trial are terminal cancer patients with not long to live suffering from aggressive forms of cancer and have failed other standards of care, so PAA and it's PPL1 is trying to treat the WORST of the WORST Cancer for which there's is no hope or cure.

If they can continue to demonstrate these results with larger sample sizes, this company will be worth a ridiculous amount of money.
Recent targeted drug therapies such as Herceptin and Avastin have reached over $6billion in annual sales and these drugs are not without serious side effects and toxicity. The fact that PAA's drug, Monepantel, has widely been used in animals means that this is a drug which is highly unlikely to present any significant toxic effects in humans (Unlike Herceptin and Avastin).

A chemotherapeutic agent such as this DOES NOT EXIST in our society. This drug could completely revolutionise the oncology world and the world of those patient's suffering from this terrible disease.

It's only early stages, but it's only capped at $20mill... there is no way that this company won't increase atleast 5-fold from here.

Expand

Yes definitely second most exciting cancer drug spec.....behind NRT of course

Seriously though very happy with PAA - and agree great investment for market cap position...for what achieved so far with PPL....

PAA Price at posting: 1.3¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

US election outcomes: Key economic and market takeaways

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

PNN

Power gets set for 1000-metre maiden drilling program in Brazil

First 115 Last

Add NUZ (ASX) to my watchlist

(20min delay)
Last 18.5¢		Change -0.015(7.50%)		Mkt cap ! $90.96M

Open	High	Low	Value	Volume
20.0¢	20.5¢	18.5¢	$106.2K	550.9K

Buyers (Bids)

No.	Vol.	Price($)
11	714303	18.5¢

Sellers (Offers)

Price($)	Vol.	No.
19.0¢	26750	1

View Market Depth

No.	Vol.	Price($)
11	714303	0.185
8	384080	0.180
5	151797	0.175
7	208030	0.170
1	60000	0.165

Price($)	Vol.	No.
0.190	26750	1
0.195	108645	5
0.205	106604	5
0.210	148876	3
0.215	154400	2

Last trade - 16.10pm 18/11/2024 (20 minute delay)

NUZ (ASX) Chart

Ann: Lyell McEwin Hospital approved to join PharmAust trial, page-115

US election outcomes: Key economic and market takeaways

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Power gets set for 1000-metre maiden drilling program in Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Lyell McEwin Hospital approved to join PharmAust trial, page-115

Top Stories

US election outcomes: Key economic and market takeaways

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Quit before you're fired: Russia bans uranium exports to USA, duplicating extant US ban

Power gets set for 1000-metre maiden drilling program in Brazil

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News